Effects of silica nanoparticles on endolysosome function in primary cultured neurons

Yan Ye, Liang Hui, Koffi L. Lakpa, Yuqian Xing, Hannah Wollenzien, Xuesong Chen, Julia Xiaojun Zhao, Jonathan Geiger

Research output: Contribution to journalArticle

Abstract

Silica nanoparticles (SiNPs) have been used as vehicles for drug delivery, molecular detection, and cellular manipulations in nanoneuromedicine. SiNPs may cause adverse effects in the brain including neurotoxicity, neuroinflammation, neurodegeneration, and enhancing levels of amyloid beta (Aβ) protein—all pathological hallmarks of Alzheimer’s disease. Therefore, the extent to which SiNPs influence Aβ generation and the underlying mechanisms by which this occurs deserve investigation. Our studies were focused on the effects of SiNPs on endolysosomes which uptake, traffic, and mediate the actions of SiNPs. These organelles are also where amyloidogenesis largely originates. We found that SiNPs, in primary cultured hippocampal neurons, accumulated in endolysosomes and caused a rapid and persistent deacidification of endolysosomes. SiNPs significantly reduced endolysosome calcium stores as indicated by a significant reduction in the ability of the lysosomotropic agent glycyl-L-phenylalanine 2-naphthylamide (GPN) to release calcium from endolysosomes. SiNPs increased Aβ 1–40 secretion, whereas 2 agents that acidified endolysosomes, ML-SA1 and CGS21680, blocked SiNP-induced deacidification and increased generation of Aβ 1–40 . Our findings suggest that SiNP-induced deacidification of and calcium release from endolysosomes might be mechanistically linked to increased amyloidogenesis. The use of SiNPs might not be the best nanomaterial for therapeutic strategies against Alzheimer’s disease and other neurological disorders linked to endolysosome dysfunction.

Original languageEnglish (US)
Pages (from-to)297-305
Number of pages9
JournalCanadian journal of physiology and pharmacology
Volume97
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Silicon Dioxide
Nanoparticles
Neurons
Calcium
Alzheimer Disease
Aptitude
Nanostructures
Nervous System Diseases
Amyloid
Organelles
Brain

Keywords

  • Alzheimer’s disease
  • Amyloid beta protein
  • Endolysosomes
  • ML-SA1
  • Nanoparticles
  • SiNP
  • Silica nanoparticles

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Effects of silica nanoparticles on endolysosome function in primary cultured neurons. / Ye, Yan; Hui, Liang; Lakpa, Koffi L.; Xing, Yuqian; Wollenzien, Hannah; Chen, Xuesong; Zhao, Julia Xiaojun; Geiger, Jonathan.

In: Canadian journal of physiology and pharmacology, Vol. 97, No. 4, 01.01.2019, p. 297-305.

Research output: Contribution to journalArticle

Ye, Yan ; Hui, Liang ; Lakpa, Koffi L. ; Xing, Yuqian ; Wollenzien, Hannah ; Chen, Xuesong ; Zhao, Julia Xiaojun ; Geiger, Jonathan. / Effects of silica nanoparticles on endolysosome function in primary cultured neurons. In: Canadian journal of physiology and pharmacology. 2019 ; Vol. 97, No. 4. pp. 297-305.
@article{149b238ebfde453686d6d73b431ad0ea,
title = "Effects of silica nanoparticles on endolysosome function in primary cultured neurons",
abstract = "Silica nanoparticles (SiNPs) have been used as vehicles for drug delivery, molecular detection, and cellular manipulations in nanoneuromedicine. SiNPs may cause adverse effects in the brain including neurotoxicity, neuroinflammation, neurodegeneration, and enhancing levels of amyloid beta (Aβ) protein—all pathological hallmarks of Alzheimer’s disease. Therefore, the extent to which SiNPs influence Aβ generation and the underlying mechanisms by which this occurs deserve investigation. Our studies were focused on the effects of SiNPs on endolysosomes which uptake, traffic, and mediate the actions of SiNPs. These organelles are also where amyloidogenesis largely originates. We found that SiNPs, in primary cultured hippocampal neurons, accumulated in endolysosomes and caused a rapid and persistent deacidification of endolysosomes. SiNPs significantly reduced endolysosome calcium stores as indicated by a significant reduction in the ability of the lysosomotropic agent glycyl-L-phenylalanine 2-naphthylamide (GPN) to release calcium from endolysosomes. SiNPs increased Aβ 1–40 secretion, whereas 2 agents that acidified endolysosomes, ML-SA1 and CGS21680, blocked SiNP-induced deacidification and increased generation of Aβ 1–40 . Our findings suggest that SiNP-induced deacidification of and calcium release from endolysosomes might be mechanistically linked to increased amyloidogenesis. The use of SiNPs might not be the best nanomaterial for therapeutic strategies against Alzheimer’s disease and other neurological disorders linked to endolysosome dysfunction.",
keywords = "Alzheimer’s disease, Amyloid beta protein, Endolysosomes, ML-SA1, Nanoparticles, SiNP, Silica nanoparticles",
author = "Yan Ye and Liang Hui and Lakpa, {Koffi L.} and Yuqian Xing and Hannah Wollenzien and Xuesong Chen and Zhao, {Julia Xiaojun} and Jonathan Geiger",
year = "2019",
month = "1",
day = "1",
doi = "10.1139/cjpp-2018-0401",
language = "English (US)",
volume = "97",
pages = "297--305",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "4",

}

TY - JOUR

T1 - Effects of silica nanoparticles on endolysosome function in primary cultured neurons

AU - Ye, Yan

AU - Hui, Liang

AU - Lakpa, Koffi L.

AU - Xing, Yuqian

AU - Wollenzien, Hannah

AU - Chen, Xuesong

AU - Zhao, Julia Xiaojun

AU - Geiger, Jonathan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Silica nanoparticles (SiNPs) have been used as vehicles for drug delivery, molecular detection, and cellular manipulations in nanoneuromedicine. SiNPs may cause adverse effects in the brain including neurotoxicity, neuroinflammation, neurodegeneration, and enhancing levels of amyloid beta (Aβ) protein—all pathological hallmarks of Alzheimer’s disease. Therefore, the extent to which SiNPs influence Aβ generation and the underlying mechanisms by which this occurs deserve investigation. Our studies were focused on the effects of SiNPs on endolysosomes which uptake, traffic, and mediate the actions of SiNPs. These organelles are also where amyloidogenesis largely originates. We found that SiNPs, in primary cultured hippocampal neurons, accumulated in endolysosomes and caused a rapid and persistent deacidification of endolysosomes. SiNPs significantly reduced endolysosome calcium stores as indicated by a significant reduction in the ability of the lysosomotropic agent glycyl-L-phenylalanine 2-naphthylamide (GPN) to release calcium from endolysosomes. SiNPs increased Aβ 1–40 secretion, whereas 2 agents that acidified endolysosomes, ML-SA1 and CGS21680, blocked SiNP-induced deacidification and increased generation of Aβ 1–40 . Our findings suggest that SiNP-induced deacidification of and calcium release from endolysosomes might be mechanistically linked to increased amyloidogenesis. The use of SiNPs might not be the best nanomaterial for therapeutic strategies against Alzheimer’s disease and other neurological disorders linked to endolysosome dysfunction.

AB - Silica nanoparticles (SiNPs) have been used as vehicles for drug delivery, molecular detection, and cellular manipulations in nanoneuromedicine. SiNPs may cause adverse effects in the brain including neurotoxicity, neuroinflammation, neurodegeneration, and enhancing levels of amyloid beta (Aβ) protein—all pathological hallmarks of Alzheimer’s disease. Therefore, the extent to which SiNPs influence Aβ generation and the underlying mechanisms by which this occurs deserve investigation. Our studies were focused on the effects of SiNPs on endolysosomes which uptake, traffic, and mediate the actions of SiNPs. These organelles are also where amyloidogenesis largely originates. We found that SiNPs, in primary cultured hippocampal neurons, accumulated in endolysosomes and caused a rapid and persistent deacidification of endolysosomes. SiNPs significantly reduced endolysosome calcium stores as indicated by a significant reduction in the ability of the lysosomotropic agent glycyl-L-phenylalanine 2-naphthylamide (GPN) to release calcium from endolysosomes. SiNPs increased Aβ 1–40 secretion, whereas 2 agents that acidified endolysosomes, ML-SA1 and CGS21680, blocked SiNP-induced deacidification and increased generation of Aβ 1–40 . Our findings suggest that SiNP-induced deacidification of and calcium release from endolysosomes might be mechanistically linked to increased amyloidogenesis. The use of SiNPs might not be the best nanomaterial for therapeutic strategies against Alzheimer’s disease and other neurological disorders linked to endolysosome dysfunction.

KW - Alzheimer’s disease

KW - Amyloid beta protein

KW - Endolysosomes

KW - ML-SA1

KW - Nanoparticles

KW - SiNP

KW - Silica nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85063892222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063892222&partnerID=8YFLogxK

U2 - 10.1139/cjpp-2018-0401

DO - 10.1139/cjpp-2018-0401

M3 - Article

VL - 97

SP - 297

EP - 305

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 4

ER -